MoneyWorks4Me

Advik Lab - Quaterly Results

21 May 2022 Evaluate
The revenue slipped marginally during the March 2022 quarter. A decline of about Rs. 0.00 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Total Profit for the quarter ended March 2022 of Rs. 4.26 millions grew from Rs.-1.52 millions Operating profit Margin for the quarter ended March 2022 further decreased to -1.85% as compared to -0.38% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 0.32 0.00 0.00 0.32 0.00 0.00
Other Income 0.04 1.82 -97.80 2.58 1.95 32.31 2.58 1.95 32.31
PBIDT -1.85 -0.38 386.84 -4.17 -39.37 -89.41 -4.17 -39.37 -89.41
Interest 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.01 0.00
PBDT -1.85 -0.38 386.84 -4.18 -39.38 -89.39 -4.18 -39.38 -89.39
Depreciation 1.28 1.31 -2.29 5.14 5.56 -7.55 5.14 5.56 -7.55
PBT -3.13 -1.69 85.21 -9.32 -44.94 -79.26 -9.32 -44.94 -79.26
TAX -7.39 -0.17 4247.06 -7.91 -0.78 914.10 -7.91 -0.78 914.10
Deferred Tax -3.80 -0.17 2135.29 -4.32 -0.78 453.85 -4.32 -0.78 453.85
PAT 4.26 -1.52 -380.26 -1.41 -44.16 -96.81 -1.41 -44.16 -96.81
Equity 191.11 191.11 0.00 191.11 191.11 0.00 191.11 191.11 0.00
PBIDTM(%) 0.00 0.00 0.00 -1303.13 0.00 0.00 -1303.13 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..